Skip to main content
. 2016 Jun;10(2):71–79.

Table 2.

Mean (standard deviation) age, duration of infertility, number of oocytes retrieved, serum LH, FSH, TSH, PRL, AMH, and serum 17-beta estradiol in the control 1, control 2, and intervention groups

Variable Control 1
(n = 24)
Control 2
(n = 22)
Intervention
(n = 20)
Total
(n = 66)
P value
One-Way
ANOVA Test
Age (years) 31.7 ± 5.1 30.6 ± 5 30.2 ± 5.4 30.9 ± 5.1 0.575
Duration of infertility (years) 6.4 ± 3.2 4.4 ± 2.4 5.6 ± 2.8 5.5 ± 2.9 0.064
Number of oocytes retrieved 11.7 ± 4.3 11.9 ± 5.4 11.1 ± 4.6 11.6 ± 4.7 0.833
      MII 7.0 ± 2.9 7.8 ± 3.5 6.9 ± 2.9 7.2 ± 3.1 0.593
      MI 2.2 ± 1.8 1.5 ± 1.5 1.5 ± 1.7 1.8 ± 1.7 0.231
      GV 2.1 ± 1.6 2.4 ± 2.3 2.5 ± 1.6 2.3 ± 1.8 0.736
Serum 17 β-estradiol*(Pg/ml) 3666.7 ± 2475.2 3782.4 ± 2091.8 4380.2 ± 3270.0 3928.1 ± 2630.4 0.649
Serum LH (IU/L) 5.06 ± 2.9 7.3 ±4.6 5.4 ± 2.4 5.9 ± 3.5 0.080
Serum FSH (IU/L) 6.2 ± 2.4 6.9 ± 2.1 6.2 ± 1.8 6.4 ±2.1 0.466
Serum TSH (μIU/L) 2.6 ± 2.0 1.9 ± 1.0 2.2 ± 1.0 2.3 ±1.4 0.385
Serum PRL (ng/ml) 124.3 ± 173.7 226.2 ± 283.7 78.7 ± 141.5 145.5 ±215.9 0.075
Serum AMH (ng/ml) 5.6 ± 5.7 3.8 ± 3.5 7.3 ±6.9 5.6 ±5.7 0.175
*

On the day of hCG administration; LH: luteinizing hormone; FSH: follicle-stimulating hormone; TSH: thyroid-stimulating hormone; PRL: prolactin; AMH: anti-mullerian hormone; MII: mature oocyte (Meiosis II); MI: immature oocyte (Meiosis I); GV: Germinal Vesicle.